Prosecution Insights
Last updated: July 17, 2026
Application No. 18/223,268

BIO-BASED MONOMERS AND POLYMERS MADE THEREFROM

Non-Final OA §112
Filed
Jul 18, 2023
Priority
Aug 10, 2020 — provisional 63/063,594 +4 more
Examiner
BLAND, ALICIA
Art Unit
1759
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Columbia Insurance Company
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
5m
Est. Remaining
62%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
357 granted / 712 resolved
-14.9% vs TC avg
Moderate +12% lift
Without
With
+11.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
27 currently pending
Career history
749
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
78.0%
+38.0% vs TC avg
§102
2.0%
-38.0% vs TC avg
§112
2.0%
-38.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 712 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, species of claim 1 in the reply filed on 6/4/26 is acknowledged. The subject matter of claim 1 has been found allowable, thus, claims 8-14 are rejoined and search has continued thereon. Claims 15-17 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected groups, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 6/4/26. Priority Claims 1-14 do not have support in the parent application and thus have an effective date of the filing of this CIP: 1/19/23. Claim 1 contains a structure that is not in the parent application, and, claim 8 has elements such as a diamine or dihydrazide dispersed in the aqueous phase which are not supported by the parent application The earliest publication of the parent application is WO 2022/035801 that is published 2/17/22 and all 4 inventors of that publication are inventors in this instant application. The ‘801 document thusly does not qualify as prior art Information Disclosure Statement The information disclosure statement (IDS) submitted on 4/21/25 has been considered by the examiner. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1, 8, and their dependents, are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1-14 recite the limitation "the bio-based monomer". There is insufficient antecedent basis for this limitation in the claim. It seems claims 1 and 8 should be amended to be “a bio-based monomer” claims 2-7 and 9-14 would have proper basis. Double Patenting Double patenting was considered over US 12473389 however the hydrazide of claim 2 was not found to meet the dihydrazide of instant claim 8. Allowable Subject Matter The following is a statement of reasons for the indication of allowable subject matter: If the above 112 rejection is corrected the claims would be free from art. Close prior art to claim 1 includes: US 2024/0026059 that exemplifies a resin in [0127] comprising vanillin methacrylate reacted with a diamine and acrylate to form a resin, however, suspension of this resin in an aqueous phase with a diamine or dihydrazide is not suggested or disclosed US 20230365487 that discloses making vanillin methacrylate but its use in aqueous compositions comprising a diamine or dihydrazide is not suggested or disclosed Stanzione (of record), Vanillin based resin for use in composite applications, Green Chem 2012, 14, 2346, that discloses a resin comprising methacrylated vanillin but the resin to form a hard transparent thermoset and its use in an aqueous dispersion with a diamine or dihydrazide is not suggested or disclosed Zhang, A sustainable waterborne vanillin eugenol acrylate miniemulsion with suitable antibacterial properties as a substitute for the styrene acrylate emulsion, Green Chem, 2021, 23, 7576, which has an acrylate vanillin copolymer but does not disclose the use of a diamine or dihydrazide Close prior art to claim 1 and also the closest prior art to claim 8 (which was previously set forth in the parent application) includes: Hong US 2002/0009595. Therein Ex 4 is the closest in structure to claim 1 but does not meet the structure of claim 1. Further, as set forth in the parent, though a resin is disclosed that meets the resin of claim 8 its use as a paint composition is not suggested or disclosed Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALICIA BLAND whose telephone number is (571)272-2451. The examiner can normally be reached Mon - Fri 9:00 am -3:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Curt Mayes can be reached at 571-272-1234. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALICIA BLAND/ Primary Examiner, Art Unit 1759
Read full office action

Prosecution Timeline

Jul 18, 2023
Application Filed
Jun 16, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679962
POLYOLEFIN COMPOSITIONS OBTAINED FROM RECYCLED POLYOLEFINS
3y 1m to grant Granted Jul 14, 2026
Patent 12679914
POLYMERIZATION OF DIOL BIS(ALLYL CARBONATES) USING A MIXTURE OF TWO DIFFERENT PEROXY COMPOUNDS
2y 10m to grant Granted Jul 14, 2026
Patent 12674012
METHOD OF PREPARING POLYMER
3y 2m to grant Granted Jul 07, 2026
Patent 12674054
Elastomer Composition, Sealing Material, and Method for Producing Sealing Material
3y 3m to grant Granted Jul 07, 2026
Patent 12668651
PROPYLENE-BASED POLYMER COMPOSITIONS HAVING A HIGH MOLECULAR WEIGHT TAIL
3y 11m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
62%
With Interview (+11.6%)
3y 5m (~5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 712 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month